- Home
- SGMT vs CPHC Comparison
SGMT vs CPHC Comparison
Compare SGMT & CPHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMT
- CPHC
- Stock Information
- Founded
- SGMT 2006
- CPHC 1994
- Country
- SGMT United States
- CPHC United States
- Employees
- SGMT N/A
- CPHC N/A
- Industry
- SGMT
- CPHC Services-Misc. Amusement & Recreation
- Sector
- SGMT
- CPHC Consumer Discretionary
- Exchange
- SGMT Nasdaq
- CPHC Nasdaq
- Market Cap
- SGMT 93.7M
- CPHC 94.6M
- IPO Year
- SGMT 2023
- CPHC 1994
- Fundamental
- Price
- SGMT $5.18
- CPHC $20.44
- Analyst Decision
- SGMT Strong Buy
- CPHC
- Analyst Count
- SGMT 5
- CPHC 0
- Target Price
- SGMT $21.60
- CPHC N/A
- AVG Volume (30 Days)
- SGMT 772.8K
- CPHC 3.8K
- Earning Date
- SGMT 11-13-2024
- CPHC 11-07-2024
- Dividend Yield
- SGMT N/A
- CPHC 1.47%
- EPS Growth
- SGMT N/A
- CPHC N/A
- EPS
- SGMT N/A
- CPHC 0.94
- Revenue
- SGMT $2,000,000.00
- CPHC $62,111,814.00
- Revenue This Year
- SGMT N/A
- CPHC N/A
- Revenue Next Year
- SGMT N/A
- CPHC N/A
- P/E Ratio
- SGMT N/A
- CPHC $21.14
- Revenue Growth
- SGMT N/A
- CPHC 0.13
- 52 Week Low
- SGMT $2.25
- CPHC $14.27
- 52 Week High
- SGMT $20.71
- CPHC $30.25
- Technical
- Relative Strength Index (RSI)
- SGMT 47.83
- CPHC 62.04
- Support Level
- SGMT $5.61
- CPHC $19.28
- Resistance Level
- SGMT $6.40
- CPHC $20.18
- Average True Range (ATR)
- SGMT 0.52
- CPHC 0.45
- MACD
- SGMT -0.10
- CPHC 0.14
- Stochastic Oscillator
- SGMT 17.57
- CPHC 97.10
About SGMT Sagimet Biosciences Inc. Series A
Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company focused on developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional lipid metabolism pathways. The company's lead drug candidate, denifanstat, is an oral, once-daily pill and selective FASN inhibitor in development for the treatment of nonalcoholic steatohepatitis (NASH).
About CPHC Canterbury Park Holding Corporation 'New'
Canterbury Park Holding Corp is in the business of pari-mutuel wagering on horse races and unbanked card games at its canterbury park racetrack and card casino facility in Minnesota. The company has four operating segments. The horse racing segment represents pari-mutuel wagering operations on simulcast and lives horse races; the Casino segment represents unbanked card operations; the food and beverage segment includes concessions, catering, and events services provided at the Racetrack; and the development segment represents its real estate development operations. The firm generates a majority of its revenue from the Casino segment.